MedPath
EMA Product

Purevax RCPCh FeLV

Product approved by European Medicines Agency (EU)

Basic Information

Purevax RCPCh FeLV

Regulatory Information

EMEA/V/C/000085

Authorised

October 11, 2024

Active Substances Detail

attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)inactivated feline calicivirosis antigens (FCV 431 and G1 strains)attenuated feline panleucopenia virus (PLI IV)FeLV recombinant canarypox virus (vCP97)attenuated Chlamydophila felis (905 strain)

attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)

inactivated feline calicivirosis antigens (FCV 431 and G1 strains)

attenuated feline panleucopenia virus (PLI IV)

FeLV recombinant canarypox virus (vCP97)

attenuated Chlamydophila felis (905 strain)

Detailed Information

Overview Summary

Up-to-date information on this veterinary medicinal product is available on the [Veterinary Medicines Information website](https://medicines.health.europa.eu/veterinary/select-language?destination=/node/210934 "(opens in a new window)")

© Copyright 2025. All Rights Reserved by MedPath